Company Filing History:
Years Active: 2012
Title: Jesper Kastrup: Innovator in Antibody Cloning Technology
Introduction
Jesper Kastrup is a notable inventor based in Stenløse, Denmark. He has made significant contributions to the field of biotechnology, particularly in the area of antibody cloning. His innovative work has led to advancements that are crucial for the development of therapeutic antibodies.
Latest Patents
Jesper Kastrup holds a patent for a "Method for cloning cognate antibodies." This invention relates to a procedure for linking cognate pairs of V and V encoding sequences from a population of cells enriched in particular surface antigen markers. The linking procedure involves a multiplex molecular amplification technique capable of linking nucleotide sequences of interest during amplification, specifically through polymerase chain reaction (multiplex PCR). This method is particularly advantageous for generating cognate pair libraries and combinatorial libraries of variable region encoding sequences from immunoglobulins. Additionally, the invention encompasses methods for generating chimeric human/non-human antibodies and expression libraries created by such methods. He has 1 patent to his name.
Career Highlights
Jesper Kastrup has had a distinguished career in the biotechnology sector. He is currently associated with Symphogen A/S, where he continues to work on innovative solutions in antibody technology. His expertise and contributions have positioned him as a key figure in his field.
Collaborations
Throughout his career, Jesper has collaborated with notable professionals, including Lars Soegaard Nielsen and Per-Johan Meijer. These collaborations have further enhanced his research and development efforts in biotechnology.
Conclusion
Jesper Kastrup's work in antibody cloning technology exemplifies the impact of innovation in biotechnology. His contributions are paving the way for future advancements in therapeutic applications.